Mark Lynas and the demeaning of science
He’s fuzzy on facts and low on science, but the campaigner gets big media support
A pre-emptive strike against Monsanto
American organic farmers are trying to ensure the biotech giant cannot sue them
Pursuing a nationalist IPR policy
India has enough laws to protect its intellectual property rights. It is the implementation that is wanting
Bringing Google to book
Google’s digital library project went too far, creating a monopoly over the heritage of books
Patent issues delaying Ebola cure
Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine
What Durban did not discuss
IPRs are blocking access to mitigation and adaptation technologies. India offers a way out
Disclosure-shy industry
Pharma and biotech firms are lobbying hard to block disclosure of origin of genetic material used in inventions, but they also raise thorny issues
New endosulfan ploy
Industry is sidestepping issues by pitching the proposed UN ban on endosulfan as the battle between generics and patented pesticides
Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global
WTO gives India a clean chit
Apex trade regulator finds nothing amiss in India's intellectual property laws after exhaustive review
Unholy smoke!
Inclusion of intellectual property in bilateral investment agreements is injurious to the health of developing nations
Testing the CL route
Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs
Big tobacco blows new smoke rings
A third front has opened up in their war on Australia’s cigarette packaging rules
Standing up to the US
India does not have to be apologetic about its patents law, which is fully compliant with WTO requirements on intellectual property protection
ICAR chases patents for pickle
The National Research Centre on Meat has odd ideas on what can be patented
‘PESTICIDES’ IN DRUGS
Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too
Wooing the judges, openly
There is conflict of interest as US patent owners schedule meetings with Indian judiciary and patent regulators
Big step for biocultural rights
The Nagoya Protocol promotes community stewardship of genetic resources. India needs to foster this
Trail of a $500 m gene
How a rare African algae collected by a French academic turns into a commercial bonanza for an equity firm in Hong Kong. Are there any benefits …